Advanced Cell Gets $25M Funding Commitment

Socius Capital Group, the private investment firm, has invested $25 million in listed, OTCBB-listed Advanced Cell Technology. The investment firm did so via subsidiary Socius CG II Ltd.; it acquired $25 million through a non-convertible stock purchase agreement. A statement released by both parties indicated Advanced Cell Technology would use the funding for clinical trials and general corporate purposes.

DealsNorth AmericaUSBriefs